Volume 26, Number 11—November 2020
Two New Cases of Pulmonary Infection by Mycobacterium shigaense, Japan
||Mapped region to reference genome†
||Pseudogenome by BactSNP, bases
|Case 2, NB-type, KC354||19||5,232,622||0.99999||5,182,569|
|Case 1, FC-type, KC8||6,826||5,200,032||0.99376||5,138,016|
*SNPs called by BactSNP pipeline (9). FC, fibrocavitary; NB, nodular bronchiectasis; SNP, single-nucleotide polymorphism. †Coverage depth is >5 at each position of the reference genome (5,232,660).
- Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al.; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.
- Hoefsloot W, van Ingen J, Andrejak C, Ängeby K, Bauriaud R, Bemer P, et al.; Nontuberculous Mycobacteria Network European Trials Group. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42:1604–13.
- Hwang JA, Kim S, Jo KW, Shim TS. Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course. Eur Respir J. 2017;49:
- Nakanaga K, Hoshino Y, Wakabayashi M, Fujimoto N, Tortoli E, Makino M, et al. Mycobacterium shigaense sp. nov., a novel slowly growing scotochromogenic mycobacterium that produced nodules in an erythroderma patient with severe cellular immunodeficiency and a history of Hodgkin’s disease. J Dermatol. 2012;39:389–96.
- Fukano H, Yoshida M, Kazumi Y, Fujiwara N, Katayama K, Ogura Y, et al. Mycobacterium shigaense sp. nov., a slow-growing, scotochromogenic species, is a member of the Mycobacterium simiae complex. Int J Syst Evol Microbiol. 2018;68:2437–42.
- Fukano H, Hiranuma O, Matsui Y, Tanaka S, Hoshino Y. The first case of chronic pulmonary Mycobacterium shigaense infection in an immunocompetent patient. New Microbes New Infect. 2019;33:
- Clinical and Laboratory Standards Institute. Woods GL, Wengenack NL, Lin G, Brown-Elliott BA, Cirillo DM, Conville PS, et al. Performance standards for susceptibility testing of Mycobacteria, Nocardia spp., and other aerobic Actinomycetes, 2018. M62, 1st ed. Wayne (PA): The Institute, 2018.
- Richter M, Rosselló-Móra R, Oliver Glöckner F, Peplies J. JSpeciesWS: a web server for prokaryotic species circumscription based on pairwise genome comparison. Bioinformatics. 2016;32:929–31.
- Yoshimura D, Kajitani R, Gotoh Y, Katahira K, Okuno M, Ogura Y, et al. Evaluation of SNP calling methods for closely related bacterial isolates and a novel high-accuracy pipeline: BactSNP. Microb Genom. 2019;5:
- Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MT, et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31:3691–3.
- Bouam A, Armstrong N, Levasseur A, Drancourt M. Mycobacterium terramassiliense, Mycobacterium rhizamassiliense and Mycobacterium numidiamassiliense sp. nov., three new Mycobacterium simiae complex species cultured from plant roots. Sci Rep. 2018;8:9309.
- Shu C-C, Lee C-H, Hsu C-L, Wang J-T, Wang J-Y, Yu C-J, et al.; TAMI Group. Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns. Hai. 2011;189:467–74.
- Aksamit TR, Philley JV, Griffith DE. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials. Respir Med. 2014;108:417–25.
- Griffith DE, Philley JV. The new “Hesitation Blues”: initiating Mycobacterium avium complex lung disease therapy. Eur Respir J. 2017;49:
- Koizumi Y, Shimizu K, Shigeta M, Minamiguchi H, Hodohara K, Andoh A, et al. Mycobacterium shigaense causes lymph node and cutaneous lesions as immune reconstitution syndrome in an AIDS patient: the third case report of a novel strain non-tuberculous Mycobacterium. Intern Med. 2016;55:3375–81.
1These authors contributed equally to this article.
Page created: July 16, 2020
Page updated: October 19, 2020
Page reviewed: October 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.